Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts

• Publication date: January 2012

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs...

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance. Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.

Highlights

• Analyzes and evaluates inhaled drugs currently in development and assesses the market potential for existing and probable future products
• Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
• Provides detailed assessments of targeted disease segments, forecast growth and market potential, and therapeutic options
• Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets and prescribing decisions to 2016

Drug Delivery Technology Industry

Executive Summary

Inhaled Drug Market Dynamics

Therapeutic Targets
Demographics and Growth
Competing Technologies
Market Drivers
Factors Limiting Growth

Inhalation Technology & Product
Development Factors

Drug Formulations
Formulation Technologies
Excipients and Release Profiles
Inhalation Device Design Factors
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound Stability
Combination Drug Inhalers
Testing and Packaging
Emerging Device Technologies

Inhalation Devices – Device
Assessments and Product Strategies
Dry Powder inhalers
Commercial Devices
Development-stage DPI Devices
Metered Dose Inhalers
Nebulizers
Compressed Air Nebulizers
Ultrasonic Nebulizers
Advanced Technology Nebulizers

Inhaled Drugs – Therapeutic Segment
Analysis & Forecasts
Upper Respiratory Indications
Asthma/COPD
Allergic Rhinitis

Systemic Drug Delivery
Anaphylaxis
Bioterror
Cardiovascular Medicine
Diabetes
Hereditary Diseases
Immunology
Infectious Diseases
Osteoporosis
Neurology
Oncology
Pain Management
Sexual Health

Market Factors
Device Packaging
Regulatory Issues
Patient Compliance
The Role of CMOs/CSOs
Healthcare Economics

Market Sector Company Profiles